Cargando…

Toll-Like Receptor Expression in the Blood and Brain of Patients and a Mouse Model of Parkinson’s Disease

BACKGROUND: Accumulating evidence supports a role for the immune system in the pathogenesis of Parkinson’s disease. Importantly, recent preclinical studies are now suggesting a specific contribution of inflammation to the α-synuclein-induced pathology seen in this condition. METHODS: We used flow cy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drouin-Ouellet, Janelle, St-Amour, Isabelle, Saint-Pierre, Martine, Lamontagne-Proulx, Jérôme, Kriz, Jasna, Barker, Roger A., Cicchetti, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438545/ https://www.ncbi.nlm.nih.gov/pubmed/25522431 http://dx.doi.org/10.1093/ijnp/pyu103

Ejemplares similares

Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson’s disease
por: St-Amour, Isabelle, et al.
Publicado: (2012)

The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
por: Drouin-Ouellet, Janelle, et al.
Publicado: (2011)

A novel wireless brain stimulation device for long-term use in freely moving mice
por: Alpaugh, Melanie, et al.
Publicado: (2019)

Dermal fibroblasts from patients with Parkinson’s disease have normal GCase activity and autophagy compared to patients with PD and GBA mutations
por: Collins, Lucy M, et al.
Publicado: (2018)

The role of tau in the pathological process and clinical expression of Huntington’s disease
por: Vuono, Romina, et al.
Publicado: (2015)

Association Between Toll‐Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Genetic Variants and Clinical Progression of Huntington's Disease
por: Vuono, Romina, et al.
Publicado: (2019)

Parkinson's Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson's Disease, If Anything?
por: Drouin-Ouellet, J., et al.
Publicado: (2012)

Platelet abnormalities in Huntington’s disease
por: Denis, Hélèna L, et al.
Publicado: (2019)

Cell‐based therapy for Parkinson's disease: A journey through decades toward the light side of the Force
por: Parmar, Malin, et al.
Publicado: (2018)

Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury
por: Bohacek, Ivan, et al.
Publicado: (2012)

Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned?
por: Drouin-Ouellet, Janelle, et al.
Publicado: (2017)

Simple Generation of a High Yield Culture of Induced Neurons from Human Adult Skin Fibroblasts
por: Shrigley, Shelby, et al.
Publicado: (2018)

Three-Dimensional Analysis of Sex- and Gonadal Status- Dependent Microglial Activation in a Mouse Model of Parkinson’s Disease
por: Isenbrandt, Amandine, et al.
Publicado: (2023)

A quantitative model of cellular decision making in direct neuronal reprogramming
por: Merlevede, Adriaan, et al.
Publicado: (2021)

Reprogramming Human Adult Fibroblasts into GABAergic Interneurons
por: Bruzelius, Andreas, et al.
Publicado: (2021)

Early-Stage Treatment with Withaferin A Reduces Levels of Misfolded Superoxide Dismutase 1 and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Patel, Priyanka, et al.
Publicado: (2014)

Current Understanding of the Glial Response to Disorders of the Aging CNS
por: Barker, Roger A, et al.
Publicado: (2012)

Neurodegenerative disorders: the Glia way forward
por: Barker, Roger A., et al.
Publicado: (2014)

The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
por: Cicchetti, Francesca, et al.
Publicado: (2014)

Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD
por: Kumar, Sunny, et al.
Publicado: (2021)

The Morphological and Molecular Changes of Brain Cells Exposed to Direct Current Electric Field Stimulation
por: Pelletier, Simon J., et al.
Publicado: (2015)

Sex and Age Differences in a Progressive Synucleinopathy Mouse Model
por: Lamontagne-Proulx, Jérôme, et al.
Publicado: (2023)

The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
por: Heidari, Arash, et al.
Publicado: (2022)

Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
por: Noelker, Carmen, et al.
Publicado: (2013)

A light-inducible protein clustering system for in vivo analysis of α-synuclein aggregation in Parkinson disease
por: Bérard, Morgan, et al.
Publicado: (2022)

Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson’s disease
por: Drouin-Ouellet, Janelle, et al.
Publicado: (2022)

GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte–neuron interactions
por: L'Episcopo, F, et al.
Publicado: (2016)

Toll‐like receptor‐2 exacerbates murine acute viral hepatitis
por: Bleau, Christian, et al.
Publicado: (2016)

The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal Biorepository
por: Gan-Or, Ziv, et al.
Publicado: (2020)

Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease
por: Pircs, Karolina, et al.
Publicado: (2021)

Author Correction: Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
por: Noelker, Carmen, et al.
Publicado: (2023)

Toll-like Receptor Activation Induces Degeneration of Human Intervertebral Discs
por: Krock, Emerson, et al.
Publicado: (2017)

Neural tube patterning: from a minimal model for rostrocaudal patterning toward an integrated 3D model
por: Brambach, Max, et al.
Publicado: (2021)

IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology
por: St-Amour, Isabelle, et al.
Publicado: (2014)

Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease
por: Caputi, Valentina, et al.
Publicado: (2018)

Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
por: Poirier, Andrée-Anne, et al.
Publicado: (2022)

Toll‐like receptor involvement in adolescent scoliotic facet joint degeneration
por: Bisson, Daniel G., et al.
Publicado: (2020)

Effect of Docosahexaenoic Acid (DHA) at the Enteric Level in a Synucleinopathy Mouse Model
por: Lamontagne-Proulx, Jérôme, et al.
Publicado: (2021)

Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms
por: Masnata, Maria, et al.
Publicado: (2019)

CD36 neutralisation blunts TLR2-IRF7 but not IRF3 pathway in neonatal mouse brain and immature human microglia following innate immune challenge
por: Gadagkar, Shruti Gururaj, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kd22bddqfprgsi1lqaab1pd8jj